Top

Published in:

01-04-2015 | Case report

Afamelanotide

Fatigue: case report

Published in: Reactions Weekly | Issue 1/2015

Excerpt

A phase II open-label pilot study identified a male patient [age not stated] who developed fatigue while receiving afamelanotide. The patient had mild-to-moderate facial acne vulgaris. He started receiving afamelanotide 16mg, administered as a sustained release resorbable implant formulation and as SC injections into fat above the anterior portion of the iliac crest [frequency not stated]. He experienced mild and short-term fatigue [time to reaction onset not stated]. …

Bohm M, et al. Beneficial effects of the melanocortin analogue Nle4-D-Phe 7-alpha-MSH in acne vulgaris. Journal of the European Academy of Dermatology and Venereology 28: 108-111, No. 1, Jan 2014. Available from: URL: http://doi.org/10.1111/j.1468-3083.2012.04658.x - GermanyCrossRefPubMed

Title: Afamelanotide
Fatigue: case report
Publication date: 01-04-2015
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-015-9108-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Afamelanotide

Fatigue: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2015

Aspirin/fluindione/heparin

Antituberculars

Paliperidone

Metformin

Miconazole

Dexamethasone